Bliss GVS Pharma Ltd
company logo

Bliss GVS Pharma Ltd

Bliss GVS Pharma Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Bliss GVS Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Bliss GVS Pharma Ltd Performance

-

-

-

-


-

-

-

-

-

Bliss GVS Pharma Ltd Fundamentals

Read More

1,358.40Cr

16.15

1.35

0.11

7.99

0.39%

95.91

Bliss GVS Pharma Ltd Financials

Bliss GVS Pharma Ltd Financialsright-arrow

Bliss GVS Pharma Ltd Shareholding Pattern

Bliss GVS Pharma Ltd Delivery and Volume

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984. The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limi

Gagan Harsh Sharmma

1984

BLISSGVS

NameDesignation
Vibha G SharmaWhole-time Director
Shruti Vishal RaoWhole-time Director
Santosh ParabNon-Exec. & Independent Dir.
Aditi BhattCompany Sec. & Compli. Officer
Shilpa BhatiaNon-Exec. & Independent Dir.
Gagan Harsh SharmmaManaging Director
Nandkumar Kashinath ChodankarChairman
News and Events...

Similar Stocks

What's Trending

View All
View All

Bliss GVS Pharma Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Bliss GVS Pharma Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Bliss GVS Pharma Ltd's share price is ₹129.06 as of 2024-11-22.
Bliss GVS Pharma Ltd's P/E ratio is 16.15 times as of 2024-11-22.
Bliss GVS Pharma Ltd's most recent financial reports indicate a price-to-book ratio of 1.35, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Bliss GVS Pharma Ltd's market capitalization is ₹1358.4 Cr as on 2024-11-22.
The current financial records of Bliss GVS Pharma Ltd show a 7.91% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Bliss GVS Pharma Ltd's most recent financial filings, the company has a total asset value of ₹797.3, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Bliss GVS Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Bliss GVS Pharma Ltd's 52-week high and low as of 2024-11-22 are ₹131.4 and ₹119.77, respectively.